EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

Pityriasis rubra pilaris: сlinical forms, triggers and disease course

M.E. Zapolskiy, T.V. Chaban, D.M. Zapolska, L.M. Tymofieieva

Ukrainian Journal of Dermatology, Venereology, Cosmetology · 30.05.2026 · (2) · 5-12

DOI: 10.30978/ujdvk2026-2-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ukrainian Journal of Dermatology, Venereology, Cosmetology, online erschienen am 30.05.2026. Verfasst von M.E. Zapolskiy und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pityriasis rubra pilaris (Devergie’s disease — DD) is a rare chronic polyetiological dermatosis with diverse clinical manifestations, which complicates timely diagnosis and the selection of optimal therapy. Objective — to analyze clinical features and trigger factors of different forms of pityriasis rubra pilaris. Materials and methods. A retrospective analysis of 23 patients with different forms of pityriasis rubra pilaris who were followed up between 2019 and 2025 was performed. Clinical manifestations, trigger factors, disease course, and treatment efficacy were evaluated. Results and discussion. The most common clinical variant was the classical adult type (60.9 %), characterized by a relatively predictable course (3—6 months). Atypical forms were less frequent (13.0 %) but demonstrated a more prolonged and persistent course. Palmoplantar keratoderma was a characteristic clinical feature of pityriasis rubra pilaris which determined its diagnostic and prognostic significance. In 34.8 % of cases, disease onset was associated with viral infections (acute respiratory viral infections — 17.4 %, HIV infection — 8.7 %, COVID-19 — 8.7 %). HIV-associated cases were characterized by a more severe course with regression observed during antiretroviral therapy. Severe forms, particularly erythroderma, were associated with significant deterioration of the general condition and limited effectiveness of conventional treatment. The use of IL-17 inhibitors demonstrated a positive clinical effect in resistant cases. Conclusions. Pityriasis rubra pilaris is a multifactorial dermatosis in which viral infections play an important role. Clinical forms differ significantly in course and prognosis, which requires a personalized diagnostic and therapeutic approach. Targeted therapy, in particular IL-17 inhibitors, appears to be a promising option for the treatment of severe forms of the disease.

Zitieren

APA

Zapolskiy, M., Chaban, T., Zapolska, D., & Tymofieieva, L. (2026). Pityriasis rubra pilaris: сlinical forms, triggers and disease course. Ukrainian Journal of Dermatology, Venereology, Cosmetology, 5-12. https://doi.org/10.30978/ujdvk2026-2-5

Vancouver

Zapolskiy M, Chaban T, Zapolska D, Tymofieieva L. Pityriasis rubra pilaris: сlinical forms, triggers and disease course. Ukrainian Journal of Dermatology, Venereology, Cosmetology. 2026:5-12. doi:10.30978/ujdvk2026-2-5

BibTeX
@article{Zapolskiy2026,
  author = {Zapolskiy, M.E. and Chaban, T.V. and Zapolska, D.M. and Tymofieieva, L.M.},
  title = {Pityriasis rubra pilaris: сlinical forms, triggers and disease course},
  journal = {Ukrainian Journal of Dermatology, Venereology, Cosmetology},
  year = {2026},
  number = {2},
  pages = {5--12},
  doi = {10.30978/ujdvk2026-2-5}
}
Kostenlos starten →